EDITORIAL COMMENT   Free access

Minerva Urology and Nephrology 2022 August;74(4):475-8

DOI: 10.23736/S2724-6051.22.04946-1

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Comment on: “Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications”

Enrico CHECCUCCI ^{1, 2, 3} ✉, Gabriele VOLPI ², Sabrina DE CILLIS ², Federico PIRAMIDE ², Alberto PIANA ², Alessandro VECCIA ⁴, Ugo FALAGARIO ⁵, Davide LOIZZO ^{6, 7}, Savio D. PANDOLFO ^{7, 8}, Riccardo AUTORINO ⁷ ✉, Daniele AMPARORE ²

¹ Department of Surgery, Candiolo Cancer Institute - FPO-IRCCS, Candiolo, Turin, Italy; ² Division of Urology, Department of Oncology, University of Turin, Turin, Italy; ³ Uro-technology and SoMe Working Group of the Young Academic Urologists (YAU) Working Party of the European Association of Urology (EAU), Arnhem, the Netherlands; ⁴ Unit of Urology, ASST Carlo Poma Hospital, Mantua, Italy; ⁵ Department of Urology and Organ Transplantation, University of Foggia, Foggia, Italy; ⁶ Unit of Urology, Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy; ⁷ Division of Urology, VCU Health, Richmond, VA, USA; ⁸ Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, University of Naples Federico II, Naples, Italy